Chimeric antigen receptor T cell therapy followed by unrelated cord blood transplantation for the treatment of relapsed/refractory B-cell ALL in children and young adults: superior survival but relatively high posttransplant relapse
Chimeric antigen receptor T cell therapy followed by unrelated cord blood transplantation for the treatment of relapsed/refractory B-cell ALL in children and young adults: superior survival but relatively high posttransplant relapse
复制标题
嵌合抗原受体 T 细胞疗法随后进行无关脐带血移植治疗儿童和年轻人的复发/难治性 B 细胞 ALL：生存率较高，但移植后复发率相对较高
DOI：
--
复制
发表时间：
2022
影响因子：
3.2
通讯作者：
Zimin Sun
中科院分区：
文献类型：
--
作者：
Guangyu Sun;Baolin Tang;Xiang Wan;Wen Yao;Kaidi Song;Meijuan Tu;Liangquan Geng;Ping Qiang;Yue Wu;Lijun Zhu;Yun Wu;Huilan Liu;Xiaoyu Zhu;Zimin Sun
Guangyu Sun，Baolin Tang，Xiang Wan，Wen Yao，Kaidi Song，Meijuan Tu，Liangquan Geng，Ping Qiang，Yue Wu，Lijun Zhu，Yun Wu，Huilan Liu，Xiaoyu Zhu*，Zimin Sun
Guangyu Sun, Baolin Tang, Xiang Wan, Wen Yao, Kaidi Song, Meijuan Tu, Liangquan Geng, Ping Qiang, Yue Wu, Lijun Zhu, Yun Wu, Huilan Liu, Xiaoyu Zhu*, Zimin Sun